Walgreens misses FY24 profit estimate
Walgreens' lower forecast comes at a time when the company is facing multiple challenges, like persistently weak prescription drug demand, reported walkouts by its pharmacy staff and a shift in focus towards integrated health services. It has also contended with weak sales of its consumer health products due to persistently high inflation. The company reported a 4.3% fall in U.S. retail sales and a 0.5% decline in total prescriptions filled, including vaccinations, in the fourth quarter.